Next Generation CD19 CAR-T for the treatment of lymphoid malignancies

Chimeric Antigen Receptor Engineered Natural Killer Cells as a Carrier of Drug-Encapsulated Nanoparticles Targeting Adenosine Receptors in Ovarian Cancer

Characterizing the immune microenvironment of lymphoma and myeloma using multiplexed imaging mass cytometry

insert text